Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: A longitudinal and prospective study

American Journal of Geriatric Psychiatry

Volumn 16, Issue 1, 2008, Pages 5-13

  Benítez, Carlos Israel Pérez ^a   Smith, Kevin ^a   Vasile, Russell G ^b   Rende, Richard ^a   Edelen, Maria Orlando ^a   Keller, Martin B ^a  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antianxiety agents; Anxiety disorders; Longitudinal course

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; FLUOXETINE; LORAZEPAM; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE; ANXIOLYTIC AGENT; NORADRENALIN;

ADULT; AGED; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG USE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; GENERALIZED ESTIMATING EQUATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MULTICENTER STUDY; PANIC; PROSPECTIVE STUDY; RELIABILITY; SOCIAL PHOBIA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURED INTERVIEW; AGE DISTRIBUTION; DRUG ANTAGONISM; DRUG UTILIZATION; FEMALE; MALE; MIDDLE AGED; UNITED STATES;

AGE DISTRIBUTION; AGED; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; COMORBIDITY; DRUG UTILIZATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; UNITED STATES;

EID: 39749161551     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e31815aff5c     Document Type: Article

References (39)

1. Schuurmans J, Comijs HC, Beekman ATF, et al: The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam. Acta Psychiatr Scand 2005; 111:420-428
2. Wetherell JL, Maser JD, van Balkom A: Anxiety disorders in the elderly: outdated beliefs and a research agenda. Acta Psychiatr Scand 2005; 111:401-402
3. Flint AJ: Anxiety and its disorders in late life: moving the field forward. Am J Geriatr Psychiatry 2005; 13:3-6
4. Sheikh JI: Investigations of anxiety in older adults: recent advances and future directions. J Geriatr Psychiatry Neurol 2005; 18:59-60
5. Regier DA, Boyd JH, Burke JD, et al: One-month prevalence of mental disorders in the United States: based on five epidemio-logic catchment area sites. Arch Gen Psychiatry 1988; 45:977- 986
6. Tamblyn R, Abrahamowicz M, du Berger R, et al: A 5-year prospective assessment of the risk associated with individual benzo-diazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53:233-241
7. Beekman ATF, Bremmer MA, Deeg DJH, et al: Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998; 13:717-726
8. Linden M, Bar T, Helmchen H: Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16:461-480
9. Sheikh JI, Cassidy EL: Treatment of anxiety disorders in the elderly: issues and strategies. J Anxiety Disord 2000; 14:173-190
10. Flint AJ: Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging 2005; 22:101-114
11. Bogunovic OJ, Greenfield SF, Goldstein MZ: Use of benzodiaz-epines among elderly patients. Psychiatr Serv 2004; 55:233-235
12. Lenze EJ, Pollock BG, Shear MK, et al: Treatment considerations for anxiety in the elderly. Cent Nerv Syst Spectrums 2003; 8:6-13
13. Gray SL, Eggen AE, Blough D, et al: Benzodiazepine use in older adults enrolled in a health maintenance organization. Am J Geriatr Psychiatry 2003; 11:568-576
14. Gleason P, Schulz R, Smith N, et al: Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13:243-250
15. van Balkom AJLM, Beekman ATF, de Beurs E, et al: Comorbidity of the anxiety disorders in a community-based older population in the Netherlands. Acta Psychiatr Scand 2000; 101:37-45
16. Jorm AF, Grayson D, Creasey H, et al: Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health 2000; 24:7-10
17. Fourrier A, Letenneur L, Dartigues JF, et al: Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol 2001; 57:419-425
18. Thapa PB, Brockman KG, Gideon P, et al: Injurious falls in nonam-bulatory nursing home residents: a comparative study of circumstances, incidence, and risk factors. J Am Geriatr Soc 1996; 44:273-278
19. Paterniti S, Dufouil C, Alperovitch A: Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol 2002; 22:285-293
20. Sheikh JI: Problems associated with long-term benzodiazepine use in the elderly, in Psychopharmacological Treatment Complications in the Elderly. Edited by Shamoian C. Washington, DC, American Psychiatric Association, 1992, pp et al71-87
21. Landi F, Onder G, Cesari M, et al: Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005; 60:622-626
22. Herings RM, Stricker BH, de Boer A, et al: Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 1995; 155:1801-1807
23. Gray SL, LaCroix AZ, Hanlon JT, et al: Benzodiazepine use and physical disability in community-dwelling older adults. J Am Geriatr Soc 2006; 54:224-230
24. Katz IR, Reynolds III, CF Alexopoulos GS, et al: Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc 2002; 50:18-25
25. Vasile RG, Bruce SE, Goisman RM, et al: Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 2005; 22:59-67
26. Sheikh JI: Anxiolytics, sedatives, and older patients. Prim Psychiatry 2004; 11:51-54
27. Bruce SE, Vasile RG, Goisman RM, et al: Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 2003; 160:1432-1438
28. Keller MB, Yonkers KA, Warshaw MG, et al: Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short interval naturalistic follow-up. J Nerv Ment Dis 1994; 182:290-296
29. Spitzer R, Williams J, Gibbon M, et al: Structured Clinical Interview for DSM-III-R Patient Version (SCID-P). New York, NY, Biometrics Research Department, New York State Psychiatric Institute, 1988
30. Endicott J, Spitzer R: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia (SADS-L). Arch Gen Psychiatry 1978; 35:837-844
31. Keller MB, Lavori PW, Neilson E: SCALUP (SCID + SADS-L). Available from Dr. Keller, Butler Hospital, 345 Blackstone Boulevard, Providence, RI, 02906. 1987
32. Keller MB, Lavori PW, Friedman B, et al: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540-548
33. Warshaw MG, Keller MB, Stout RL: Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders. J Psychiatr Res 1994; 28:531-545
34. Lenze EJ: Pharmacotherapeutic Management of Anxiety in the Elderly. Miami, FL, Anxiety Disorders Association of America, 2006
35. Juurlink DN, Mamdani MM, Kopp A, et al: The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 2006; 163:813-821
36. Baca E, Roca M, Garcia-Calvo C, et al: Venlafaxine extended-release in patients older than 80 years with depressive syndrome. Int J Geriatr Psychiatry 2006; 21:337-343
37. Salzman C: Late-life anxiety disorders. Psychopharmacol Bull 2004; 38:25-30
38. Goisman RM, Rogers MP, Steketee GS, et al: Utilization of behavioral methods in a multicenter anxiety disorders study. J Clin Psychiatry 1993; 54:213-218
39. Goisman RM, Warshaw MG, Keller MB: Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. Am J Psychiatry 1999; 156:1819- 1821